Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W DeGregorio

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Critical Reviews in Oncology/Hematology|November 1, 1992
Pharmacology of agents used in bone marrow transplant conditioning regimensV J Wiebe, B R Smith, M W DeGregorio, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancerV J Wiebe, C C Benz, I Shemano, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2005
Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrationsM W DeGregorio, K H Dingley, G T Wurz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Pharmacokinetics of cisplatin in patients receiving interleukin-2-containing treatment regimensD R Gandara, E A Perez, A Denham, et al.
Cancer Chemotherapy and Pharmacology|October 15, 1998
Pharmacokinetic analysis of high-dose toremifene in combination with doxorubicinG T Wurz, L Soc, V D Emshoff, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Characterization of cellular lipids in doxorubicin-sensitive and -resistant P388 mouse leukemia cellsW M Holleran, M W DeGregorio, R Ganapathi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Kinetics and sensitivity of daunorubicin in patients with acute leukemiaM W DeGregorio, W M Holleran, B A Macher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patientsC K Osborne, V J Wiebe, W L McGuire, et al.
Cancer Treatment Reports|December 1, 1982
Cellular and plasma kinetics of daunorubicin given by two methods of administration in a patient with acute leukemiaM W DeGregorio, C J Carrera, J C Klock, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Preliminary observations of intraperitoneal carboplatin pharmacokinetics during a phase I study of the Northern California Oncology GroupM W DeGregorio, B L Lum, W M Holleran, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Critical Reviews in Oncology/Hematology|November 1, 1992
Pharmacology of agents used in bone marrow transplant conditioning regimensV J Wiebe, B R Smith, M W DeGregorio, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancerV J Wiebe, C C Benz, I Shemano, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2005
Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrationsM W DeGregorio, K H Dingley, G T Wurz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Pharmacokinetics of cisplatin in patients receiving interleukin-2-containing treatment regimensD R Gandara, E A Perez, A Denham, et al.
Cancer Chemotherapy and Pharmacology|October 15, 1998
Pharmacokinetic analysis of high-dose toremifene in combination with doxorubicinG T Wurz, L Soc, V D Emshoff, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Characterization of cellular lipids in doxorubicin-sensitive and -resistant P388 mouse leukemia cellsW M Holleran, M W DeGregorio, R Ganapathi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Kinetics and sensitivity of daunorubicin in patients with acute leukemiaM W DeGregorio, W M Holleran, B A Macher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patientsC K Osborne, V J Wiebe, W L McGuire, et al.
Cancer Treatment Reports|December 1, 1982
Cellular and plasma kinetics of daunorubicin given by two methods of administration in a patient with acute leukemiaM W DeGregorio, C J Carrera, J C Klock, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Preliminary observations of intraperitoneal carboplatin pharmacokinetics during a phase I study of the Northern California Oncology GroupM W DeGregorio, B L Lum, W M Holleran, et al.
Pageof 6